Controlled substances: xylazine.
Vote required
Majority
Fiscal committee
No
Appropriation
No
Current location
Appropriations
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed Assembly
- To Governor
- Became Law
Overview
This bill addresses the growing problem of xylazine, an animal sedative increasingly found in the illicit drug supply and linked to overdose deaths. It designates xylazine as a Schedule III controlled substance, creating an exception for compounding animal drugs containing xylazine if approved by the federal Food and Drug Administration. The bill also excludes xylazine testing equipment from paraphernalia prohibitions, aiming to support legitimate veterinary uses while deterring xylazine’s spread in California’s drug market.
Key provisions
- Designates xylazine as a Schedule III controlled substance.
- Creates an exception for compounding animal drugs containing xylazine if approved by the FDA.
- Excludes xylazine testing equipment from paraphernalia prohibitions.
- Provides that no reimbursement is required for local agencies or school districts due to the creation of a new crime.
- Clarifies that the bill does not affect legitimate veterinary uses of xylazine.
- Updates Section 11014.5 to define drug paraphernalia, excluding xylazine testing equipment.
- Updates Section 11056 to include xylazine as a controlled substance.
- Updates Section 11364.5 to regulate the sale and display of drug paraphernalia.
Who is affected
- Drug users and those at risk of overdose
- First responders and emergency medical personnel
- Veterinarians and animal drug manufacturers
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
1 on record
Primary sponsor
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours